• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Framingham Heart Study in the New Millennium: Deeper Dives into CVD Risk



As FHS continues, advanced technology leads to discovery of genetic CVD risk; imaging studies refine risk assessment; gamification enters FHS research; and a 2019 grant ensures the future.

The Framingham Heart Study continues to provide a rich well of epidemiologic data that over the past 20 years has provided definitive evidence of what we now accept as fact, such as that occurrence of heart disease or stroke by age 65 years in a parent increases the risk of heart disease and stroke 2- to 3-fold in offspring. The research has broadened and deepened and now includes collaborative genetic research with other groups in large consortia that has identified hundreds of new genetic loci that contribute to the risk of developing risk factors and heart disease and stroke.

The slide show that follows picks up in the year 2000 and offers, at-a-glance, the myriad contributions made by FHS data to understanding human health and disease.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.